SLC5A2 and diabetic kidney disease: For instance, irbesartan and metformin alleviate renal apoptosis induced by advanced glycation end products (AGEs) (10, 11), while fenofibrate and sodium-glucose cotransporter 2 (SGLT2) inhibitors enhance autophagy to improve kidney function in patients with diabetic kidney disease (DKD) (12, 13).